简介：AIMTo调查在patients.METHODSNon-DSEK在接枝拒绝率，和它的全面程序的有效性上剥去endothelialkeratoplasty(non-DSEK)的non-Descemet的影响在64个病人，和程序的结果的65只眼睛上被执行包括接枝的拒绝事件，失败和脱臼，最好改正的视觉尖酸(BCVA)，endothelial房间密度(ECD)，和另外的复杂并发症，是65看的分析retrospectively.RESULTSOf，63从bullouskeratopathywi恢复了吝啬的后续时间是26.4mo(范围，6-84mo)。吝啬的BCVA在外科以后在1y在3mo，在6mo的0.46logMAR，和0.37logMAR外科手术前地从1.70logMAR改善了到0.54logMAR。成功地经历了镜子的显微镜的检查的25个病人的手术后的施主ECD是1918<

简介：AIM:Toexaminetheintegrityoftheocularsurfacesofsubjectswithandwithoutdiabeteswithnoconjunctivalanddryeyesignsandsymptomsandcompareconjunctivalimpressioncytologyfindingsindiabeticswithnon-proliferativeandproliferativediabeticretinopathy.METHODS:Conjunctivalimpressioncytologywasperformedon43eyesof43subjectswithnonproliferativediabeticretinopathy(NPDR),42eyesof42subjectswithproliferativediabeticretinopathy(PDR),and30eyesof30controlsubjects.Impressioncytologyspecimensofeachgroupweregradedandscoredintherange0-3accordingtoNelson’smethod.RESULTS:Therewere45(52.9%)womenand40(47.1%)men.Themeanageofthepatientswas59.6±9.3y(range,43-76y)inNPDRgroupand58.0±8.8y(range,41-85y)inPDRgroup.CaseswithNPDRandPDRshowedstatisticallysignificanthigherimpressioncytologyscoresthancontrolgroup(P<0.05).TherewasnodifferencebetweentheNPDRandPDRpatientsforimpressioncytologygradingscores.CONCLUSION:ItisdeterminedthatimpressioncytologygradesarealteredinpatientswithNPDRandPDR.Consequently,wesuggestthattheremightbeanassociationbetweentheimpressioncytologygradingscoresandtheseverityofdiabeticretinopathy

简介：AIM:Toestablishtheefficacyandsafetyofbimatoprost0.03%monotherapyinglaucomaandocularhypertension(OHT)patientswithinadequateintraocularpressure(IOP)oncurrenttherapy.METHODS:Pre-andpost-switchIOPswereanalyzedfor59consecutivepatientswhowereswitchedfromcurrenttherapytobimatoprostmonotherapybetween2011-2015.Demographicinformation,diagnosis,andanyadverseeventswererecorded.ChangeinIOPpost-preswitchwasanalyzedusinga2-sidedStudent'spairedt-testatthe5%significancelevel.RESULTS:TherewasastatisticallysignificantmeanreductioninIOPatthefirstfollowupvisit,whichwasmaintainedatsubsequentfollowupvisitsforpatientsregardlessofdiagnosis,orpre-switchtreatment(P<0.001).SubgroupanalysisalsodemonstratedastatisticallysignificantmeanreductioninIOPwhenlookingatOHTpatientsonly,aswellaspatientswithanydiagnosisswitchedfromlatanoprostmonotherapytobimatoprostmonotherapy(P<0.001).CONCLUSION:Thisisthelargestindependentdatasetwhichsupportsswitchingglaucomapatientswithpoorresponsetocurrenttreatmentontobimatoprostmonotherapybeforeconsideringotheradjuvantmedicalormoreinvasivetherapy.

简介：AIMTo探索在网膜的血容器的氧浸透怎么在ischemic和non-ischemic分支被改变网膜的静脉吸藏(BRVO).METHODSFiftyBRVO眼睛被划分成ischemic(n=26)和non-ischemic(n=24)组，基于宫底荧光黄angiography。健康个人(n=52和n=48，分别地)也为二个组作为控制被招募。堵塞容器和中央容器的吝啬的氧浸透被oximetry在BRVO和控制groups.RESULTSIn测量ischemicBRVO组，堵塞小动脉氧浸透(SaO2-一，106.0%±；14.3%)，而不是堵塞小静脉氧浸透(SaO2-V,60.8%±；9.4%)，看了增加什么时候与那些相比在一样的象限容器(SaO2-A,86.1%±；16.5%)在contralateral眼睛(P<；0.05)。中央容器的氧浸透堵塞容器与那些显示出类似的趋势。在non-ischemicBRVO组，堵塞，中央SaO2-V和SaO2-A没显示出重要变化。在ischemic和non-ischemicBRVO，当时，中央SaO2-A显著地被增加与健康individuals.CONCLUSIONObvious变化在相比堵塞，中央SaO2-A在ischemicBRVO组被发现，显示在小动脉的氧新陈代谢的混乱可以参予ischemicBRVO的致病。

简介：AIMTo比较特征预装，在IOL交货procedures.METHODSTotal期间，101人看的非预装的intraocular透镜(IOL)交货系统在这个未来的观察盒子系列被包括。包括iSert250NC60(NC60)的IOL的5种类型的交货特征，EnVistaMX60(MX60)，AcrySofIQSN60WF(SN60WF)，TECNISZCB00(ZCB00)，和TECNISPCB00(PCB00)被调查。NC60和PCB00经由预装的交货系统被注射，另外的IOL经由非预装的系统被注射。在人的试用，从装载到培植的结束的IOL花的时间在经历常规奔流外科的所有眼睛被测量。用4只切除猪的眼睛，在一个IOL注射者和一只猪的眼睛之间的眼的viscosurgical设备(OVD)的动力学用IOL培植的染色钠的OVD.RESULTSThe平均时间是的荧光黄被分析为NC60，为MX60的43.2年代，为SN60WF的32.3年代，为ZCB00的41.4年代，和为PCB00的14.6年代的22.0年代分别地。有有第二台仪器的IOL操作的案例的数字为MX60是6，2为ZCB00，0为SN60WF，NC60，和PCB00。推进一只猪的眼睛的OVD的数量比与非预装的systems.CONCLUSIONIOL有预装的系统的交货更快、更可预言的与一个预装的系统是更小的。而且，一个预装的交货系统相对显示出比非预装的系统推进一只猪的眼睛的更少的OVD。

简介：AIM:Toevaluatetheaccuracyofsphericalequivalent(SE)estimatesofadouble-passsystemandtocompareitwithretinoscopy,subjectiverefractionandatablemountedautorefractor.METHODS:Non-cycloplegicrefractionwasperformedon125eyesof65healthyadults(age23.5±3.0years)fromOctober2010toJanuary2011usingretinoscopy,subjectiverefraction,autorefraction(AutokeratorefractometerTOPCONKR-8100,Japan)andadoublepasssystem(OpticalQualityAnalysisSystem,OQAS,VisiometricsS.L.,Spain).Nineconsecutivemeasurementswiththedouble-passsystemwereperformedonasubgroupof22eyestoassessrepeatability.ToevaluatethetruenessoftheOQASinstrument,theSElaboratorybiasbetweenthedoublepasssystemandtheothertechniqueswascalculated.RESULTS:TheSEmeancoefficientofrepeatabilityobtainedwas0.22D.SignificantcorrelationscouldbeestablishedbetweentheOQASandtheSEobtainedwithretinoscopy(r=0.956,P<0.001),subjectiverefraction(r=0.955,P<0.001)andautorefraction(r=0.957,P<0.001).ThedifferencesinSEbetweenthedouble-passsystemandtheothertechniquesweresignificant(P<0.001),butlackedclinicalrelevanceexceptforretinoscopy;Retinoscopygavemorehyperopicvaluesthanthedouble-passsystem-0.51±0.50Daswellasthesubjectiverefraction-0.23±0.50D;Moremyopicvalueswereachievedbymeansofautorefraction0.24±0.49D.CONCLUSION:Thedouble-passsystemprovidesaccurateandreliableestimatesoftheSEthatcanbeusedforclinicalstudies.Thistechniquecandeterminethecorrectfocuspositiontoassesstheocularopticalquality.However,ithasarelativelysmallmeasuringrangeincomparisonwithautorefractors(-8.00to+5.00D),andrequirespriorinformationontherefractivestateofthepatient.